About Pledge Therapeutics
Pledge Therapeutics is a private limited company (BV/SRL) based in Leuven, founded in 2019. Its main activity is classified as "Vervaardiging van farmaceutische grondstoffen". For the 2025 financial year, Pledge Therapeutics reported a loss of €1.4 million. That makes 6 loss-making financial years in a row for Pledge Therapeutics. Revenue was not published, which is common for abbreviated accounts. The gross margin came to -€644,682. It employed an average of 6.8 full-time equivalents. Equity is negative (-€3.8 million): liabilities exceed assets. In 2020 it was -€414,267. 6 annual accounts are available, covering 2020 to 2025.
- Signals
-
Negative equityNegative equity € -3.80M
Equity is negative: debts exceed assets (technically insolvent).
Reporting lossesReporting losses € -1.40MThe company reported a loss in the latest financial year.
Poor liquidityPoor liquidity 0.02The current ratio is below 1: may be insufficient to cover short-term debt.
Negative cashflowNegative cashflow € -1.33MOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -1.33MEBITDA is negative: operating activities are loss-making.
Healthy social debtHealthy social debt 19.9%Social debts stay manageable relative to personnel costs.
Financial ratios
- Solvability > 25%
- -1,652.0%
- Liquidity > 1.0
- 0.02
- Profitability > 0%
- 36.9%
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
-645K
|
€
-97K
|
€
-144K
|
€
-89K
|
|
|
€
-1.33M
|
€
-645K
|
€
-518K
|
€
-371K
|
|
|
€
-1.40M
|
€
-689K
|
€
-559K
|
€
-408K
|
|
|
€
-3.80M
|
€
-2.40M
|
€
-1.71M
|
€
-1.15M
|
|
|
-1,651.98%
|
-819.45%
|
-472.56%
|
-333.78%
|
|
|
€
4.03M
|
€
2.69M
|
€
2.07M
|
€
1.49M
|
|
|
€
40K
|
€
35K
|
€
82K
|
€
49K
|
|
|
6.80
|
7
|
4
|
3
|
Publications 2
All publicationsFrequently asked questions
Answers to the most common questions about Pledge Therapeutics, based on official government data and the filed annual accounts.
What is the VAT number of Pledge Therapeutics?
The VAT number of Pledge Therapeutics is BE0726.743.301.
How many employees work at Pledge Therapeutics?
In 2025, Pledge Therapeutics employed 6.80 full-time equivalents (FTE).
When was Pledge Therapeutics established?
Pledge Therapeutics was founded in 14-05-2019.
What is the official address of Pledge Therapeutics?
The official address of Pledge Therapeutics is Gaston Geenslaan 1 Leuven 3001.
What is the legal form of Pledge Therapeutics?
The juridical form of Pledge Therapeutics is Private limited company (BV/SRL).
What is the annual revenue of Pledge Therapeutics?
The 2025 accounts of Pledge Therapeutics do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Pledge Therapeutics a reliable company?
Pledge Therapeutics is a registered Rechtspersoon with company number 0726.743.301 and can be verified through the official CBE database.
What is the credit limit of Pledge Therapeutics?
The estimated credit limit of Pledge Therapeutics is €0.
Is Pledge Therapeutics still active?
Pledge Therapeutics currently has the status "Normal situation" and is active.